1. Identification of new small-molecule inducers of estrogen-related receptor α (ERRα) degradation.
Peng, L., Zhang, Z., Lei, C., Li, S., Zhang, Z., Ren, X., Chang, Y., Zhang, Y., Xu, Y. and Ding, K., 2019. ACS medicinal chemistry letters, 10(5), pp.767-772.
A series of (E)-3-(4-((2,4-bis(trifluoromethyl)benzyl)oxy)-3-methoxyphenyl)-2-cyanoacrylamide derivatives were designed and synthesized as new estrogen-related receptor α (ERRα) degraders based on the proteolysis targeting chimera (PROTAC) concept. One of the representative compounds 6c is capable of specifically degrading ERRα protein by >80% at a relatively low concentration of 30 nM, becoming one of the most potent and selective ERRα degraders to date. Compound 6c could be utilized as a new powerful research tool for further biological investigation of ERRα.